Results 21 to 30 of about 625 (141)

Nail psoriasis dynamics during biologic treatment and withdrawal in patients with psoriasis who may be at high risk of developing psoriatic arthritis: a post hoc analysis of the VOYAGE 2 randomized trial

open access: yesArthritis Research & Therapy, 2023
Background Nail psoriasis is a common, physiologically, and psychologically disruptive, and yet often under-treated manifestation of psoriasis. The objectives of this analysis were to investigate the trajectory of nail psoriasis, a risk factor for ...
William Tillett   +7 more
doaj   +1 more source

Study of clinical and dermoscopic features in nails of papulosquamous disorders and their correlation with disease severity: A cross-sectional study

open access: yesIndian Journal of Dermatology, 2022
Background: As face is the index of the mind, so is the nail the index to health, as the nail is capable of mounting only a limited number of reaction patterns to the large number of disorders affecting it.
Anita Subudhi   +3 more
doaj   +1 more source

Sustained Resolution of Nail Psoriasis Through 5 Years with Ixekizumab: A Post-Hoc analysis from UNCOVER-3

open access: yesActa Dermato-Venereologica, 2022
Nail psoriasis is a chronic, difficult-to-treat condition affecting almost half of patients with psoriasis. It is associated with considerable social stigma and impairment of patients’ quality of life.
Alexander Egeberg   +7 more
doaj   +1 more source

Investigating the efficacy and safety of calcipotriol/betamethasone dipropionate foam and laser microporation for psoriatic nail disease—A hybrid trial using a smartphone application, optical coherence tomography, and patient‐reported outcome measures

open access: yesDermatologic Therapy, 2022
There is a lack of efficacious topical treatments for patients suffering from psoriatic nail disease (PND). We investigated the efficacy of Calcipotriol‐Betamethasone Dipropionate (Cal/BD) foam with and without ablative fractional laser (AFL) in patients
Vinzent Kevin Ortner   +8 more
doaj   +1 more source

Ixekizumab and Ustekinumab Efficacy in Nail Psoriasis in Patients with Moderate-to-Severe Psoriasis: 52-Week Results from a Phase 3, Head-to-Head Study (IXORA-S)

open access: yesDermatology and Therapy, 2020
Introduction Patients with plaque psoriasis often have nail psoriasis, which is difficult to treat. Ixekizumab (IXE) and ustekinumab (UST) are biologics with established efficacy in nail psoriasis.
Norman Wasel   +7 more
doaj   +1 more source

Psoriasis ungueal

open access: yesActas Dermo-Sifiliográficas, 2022
Resumen: La psoriasis ungueal puede afectar al 80% de los pacientes con psoriasis cutánea y puede ser la única manifestación en el 6% del total. Además, se correlaciona con una enfermedad psoriásica más grave, con un inicio más precoz y con una mayor ...
E. Canal-García   +3 more
doaj   +1 more source

Dermoscopic Features of Psoriatic Nails and Their Correlation to Disease Severity

open access: yesDermatology Research and Practice, 2023
Background. Nail psoriasis is a challenging chronic condition affecting patients functionally and psychologically. Nail involvement is observed in 15–80% of psoriatic patients with occasional presence of isolated nail psoriasis. Objectives.
Zeinab R. Mashal   +3 more
doaj   +1 more source

[Translated article] Nail Psoriasis

open access: yesActas Dermo-Sifiliográficas, 2022
Nail involvement in psoriasis is common. It is seen in up to 80% of patients with psoriatic lesions and may be the only manifestation in 6% of cases. Nail psoriasis is correlated with more severe disease, characterized by earlier onset and a higher risk ...
E. Canal-García   +3 more
doaj   +1 more source

Comparative study of clinical and dermoscopic features in nail psoriasis

open access: yesIndian Dermatology Online Journal, 2020
Background, Aims, and Objectives: Nail changes have been reported in approximately 40% of psoriasis patients. Occasionally nail psoriasis may be the sole finding or the first presentation of the disease.
Naphisabet Wanniang   +3 more
doaj   +1 more source

Efficacy and safety of cyclosporin, adalimumab and secukinumab in the treatment of nail psoriasis

open access: yesPifu-xingbing zhenliaoxue zazhi, 2023
Objective To assess the clinical efficacy and safety of cyclosporin, adalimumab and secukinumab in the treatment of nail psoriasis. Methods Ninety-one patients with nail psoriasis from our hospital were randomly divided into cyclosporin group (30 cases),
Zhanhan TANG   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy